Prognostic factors in Burkitt's lymphoma importance of total tumor burden

98Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In 42 patients with African Burkitt's lymphoma, we have studied biochemical and clinical correlations with prognosis. Clinical stage and anti‐EA titer were the best predictive factors, but lactic dehydrogenase (LDH) and uric acid (UA) concentrations also correlated with stage and prognosis, whereas lactic acid (LA), which was significantly elevated in Stage D, did not significantly correlate with prognosis or with LDH and UA levels. All of these factors with the possible exception of LA reflect the total body burden of tumor. We conclude that the tumor burden is the single most important prognostic factor in Burkitt's lymphoma, and that this is reflected directly by LDH and UA concentrations, and probably indirectly by anti‐EA titer. Copyright © 1980 American Cancer Society

Cite

CITATION STYLE

APA

Magrath, I., Lee, Y. J., Anderson, T., Henle, W., Ziegler, J., Simon, R., & Schein, P. (1980). Prognostic factors in Burkitt’s lymphoma importance of total tumor burden. Cancer, 45(6), 1507–1515. https://doi.org/10.1002/1097-0142(19800315)45:6<1507::AID-CNCR2820450634>3.0.CO;2-D

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free